1. Home
  2. GRPN vs REPL Comparison

GRPN vs REPL Comparison

Compare GRPN & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Groupon Inc.

GRPN

Groupon Inc.

HOLD

Current Price

$16.27

Market Cap

723.4M

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$8.94

Market Cap

781.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRPN
REPL
Founded
2008
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
723.4M
781.3M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
GRPN
REPL
Price
$16.27
$8.94
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$31.25
$12.00
AVG Volume (30 Days)
980.2K
1.3M
Earning Date
11-06-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$496,093,000.00
N/A
Revenue This Year
$4.17
N/A
Revenue Next Year
$10.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.21
$2.68
52 Week High
$43.08
$14.80

Technical Indicators

Market Signals
Indicator
GRPN
REPL
Relative Strength Index (RSI) 40.49 43.30
Support Level $17.43 $8.23
Resistance Level $17.93 $9.99
Average True Range (ATR) 0.71 0.45
MACD -0.01 -0.20
Stochastic Oscillator 15.72 36.43

Price Performance

Historical Comparison
GRPN
REPL

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: